> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection Extension Sought for Extralabel Drug Use
- URL: https://www.fdaweb.com/info-collection-extension-sought-for-extralabel-drug-use/
- Published: 2018-01-10T12:00:00.000Z
- Updated: 2026-09-14T23:12:19.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5140465

*Federal Register* notice: FDA is seeking OMB clearance for an information collection extension for “Extralabel Drug Use in Animals — 21 CFR Part 530 OMB Control Number 0910-0325.” FDA regulations permit it in certain situations to establish a safe level for a residue from the extralabel use of a drug, and to require the development of an analytical method for the detection of residues above that established safe level. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-01-10/pdf/2018-00237.pdf?ref=fdaweb.com).